TGFB1 and neoplasm: While it is not clear how topical versus systemic inhibition of TGFβ signaling may differentially affect tumor formation, taken together these data suggest that subpopulations of initiated keratinocytes may respond differently to inhibition of TGFβ signaling either within themselves or the tissue microenvironment.